Sweetnam Paulinsider trades
In SEC Form 4 filings, Sweetnam Paul is listed as CHIEF SCIENTIFIC OFFICER of Retension Pharmaceuticals, Inc. (RTSN). Sweetnam Paul reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 13.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RTSNRetension Pharmaceuticals, Inc. | CHIEF SCIENTIFIC OFFICER | 4 | Oct 13 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-13
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RTSNRetension Pharmaceuticals, Inc. | Oct 13 | Oct 13 | C | 4,026 | not reported | not reported | 406,603 | No | Form 4 |
| RTSNRetension Pharmaceuticals, Inc. | Oct 13 | Oct 13 | C | 2,640 | not reported | not reported | 2,640 | No | Form 4 |
| RTSNRetension Pharmaceuticals, Inc. | Oct 13 | Oct 13 | C · derivative | 4,026 | not reported | not reported | not reported | No | Form 4 |
| RTSNRetension Pharmaceuticals, Inc. | Oct 13 | Oct 13 | C · derivative | 2,640 | not reported | not reported | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.